Tiny artificial bronchus implant aims to help emphysema patients breathe
NCT ID NCT05087641
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early trial is testing a device called the Implantable Artificial Bronchus (IAB) in 20 adults with COPD or emphysema. The device is placed in the airways using a bronchoscope to relieve lung overinflation and improve airflow. The main goal is to check safety, looking for serious breathing-related complications, before moving to a larger effectiveness study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Implantable Artificial Bronchus (IAB) device
What this could lead to
If it works, this could point toward a new device-based treatment to help COPD/emphysema patients breathe easier by reducing lung overinflation.
What could go wrong
This is a very small, early safety trial with only 20 participants. The device involves bronchoscopic implantation and carries risks like pneumonia, airway injury, or respiratory failure. Success is far from guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, CEP 90035-003, Brazil
-
Thoraxklinik, University of Heidelberg
Heidelberg, D-69126, Germany
-
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands